Overview
New World Medical makes ophthalmic surgical devices, such as the Ahmed Glaucoma Valve and the Kahook Dual Blade, to help eye surgeons treat glaucoma and other eye conditions. The Ahmed Valve is implanted to drain fluid and lower eye pressure, while the Kahook Dual Blade is a surgical instrument used to remove tissue that blocks drainage routes, enabling better fluid flow. The company sets itself apart by working closely with surgeons to improve clinical outcomes and by donating surgical equipment to humanitarian and charitable causes in addition to its product development. Its goal is to preserve and enhance vision by delivering practical tools and technologies that benefit patients and communities.
Work here?Claim your company
Simplify's take
What believers are saying
- October 2026 MDR wins remove a regulatory barrier for three core European products.
- September 2025 ACP ST and May 2025 STREAMLINE upgrades refresh the commercial pipeline.
- Global approvals in over 20 countries support faster launches and distributor leverage.
What critics are saying
- ACP ST still lacks EU MDR certification, delaying European sales expansion beyond 2026.
- Exact product concentration leaves revenue exposed if Ahmed platform loses surgeon preference.
- No public funding disclosure or acquisition backing signals constrained scale against Alcon and Glaukos.
What makes New World Medical unique
- Ahmed ClearPath ST launched September 2025 with smaller lumen and pre-threaded suture.
- October 2026 MDR certification preserves Europe access for AGV, ACP, and KDB GLIDE.
- STREAMLINE and VIA360 broaden a glaucoma-only portfolio across implant and implant-free procedures.
Help us improve and share your feedback! Did you find this helpful?